Hvad er åbningstiderne?

Mandag 09:00 - 17:30 Tirsdag 09:00 - 17:30 Onsdag 09:00 - 17:30 Torsdag 09:00 - 17:30 Fredag 09:00 - 17:30

RetinaLyze International

Hjem
Danmark
Skovlunde
RetinaLyze International

Safe, fast and efficient retinal investigations with RetinaLyze AI and Telemedicine. Retinalyze is based on the vision to prevent loss of eyesight.

Worldwide diabetes is an increasing problem and +300 million registered diabetics (type 1 or 2) are expected in 2020. Furthermore by 2020 +250 million unregistered diabetics are expected. One of the most feared consequences of diabetes is retinal diabetic pathology since this can lead to blindness. Early diagnosis is crucial – and possible with Retinalyze. A good diabetic plan and a non-complicated laser treatment can prevent loss of sight and blindness. Our mission is to make it easier for people all over the world to have their eyes tested and prevent the tragic consequences caused by late treatment of retinal lesions. Retinalyze System A/S is a registered company in Denmark.

02/03/2026

The future of eye care in Germany – are we steering it in the right direction?

Our German distributor RetinaLyze DACH is hosting a webinar that goes straight to the heart of where optometry and ophthalmology are heading.

The title is:
“Zukunft der Augengesundheitsversorgung in die richtigen Bahnen lenken”
(Shaping the future of eye health in the right direction.)

• How screening can be implemented in daily practice without disrupting workflow
• How optometrists can take a stronger role in early detection
• How collaboration between optometry and ophthalmology can reduce pressure on clinics
• How AI-based tools such as RetinaLyze System A/S can support clinical decisions without replacing them

Primary eye care is changing. The demand for early detection of retinal disease is growing. At the same time, access to ophthalmology is strained in many regions. That gap creates both responsibility and opportunity.

If you are working in optometry, ophthalmology, or distributing diagnostic equipment in Germany, this webinar is worth your time.

Read more and sign up right here for a free webinar with Svenja Dominique Kim, Ingo Rütten, Barbara Anthonsen and Michael Anthonsen: https://www.augenscreening.eu/zukunft-der-augengesundheitsversorgung-in-die-richtigen-bahnen-lenken

25/02/2026

Transforming the patient journey with smarter questionnaires - RetinaLyze x Medibrix

One of the most underrated workflow upgrades in eye care is letting customers share the right information before they arrive.

As part of our cooperation with Medibrix, we’re excited about how their customizable pre- and post-visit questionnaires help optical stores, clinics, and ophthalmology departments work more efficiently while improving clinical quality at the same time.

Here’s what their questionnaire “brick” makes possible:
🔹 Collect health and lifestyle data before appointments
Patients arrive better prepared and clinicians get a head start.

🔹 Turn customer data into prewritten preliminary notes
Less typing, fewer manual steps, and more time focused on the actual eye exam.

🔹 Gather specific consents
Whether it’s for treatments, telemedicine services, or marketing outreach, consents are structured and stored properly.

🔹 Route customers into the right workflow
From diabetic screenings to children’s exams to dry-eye assessments, the system adapts automatically.

🔹 Provide tailored pre-visit feedback
Customers receive the relevant guidance before stepping into the store or clinic.

Together with Medibrix, we’re supporting eye care teams in creating smarter, more consistent workflows, while keeping the customer experience front and centre.

23/02/2026

“ChatGPT says I'm going blind… what do you think?”

AI-informed patients are now part of everyday eye care.
Some arrive better prepared. Others arrive more anxious.

LLMs sound confident but often lack clinical nuance and patient context.
The issue is misplaced certainty.

We wrote a short guide on how to handle AI-informed patients with empathy, structure and clinical authority.

Read it here: https://retinalyze.com/general/a-guide-to-handling-patients-whove-used-llms/

How are you experiencing this shift in optometry and ophthalmology? 👀

19/02/2026

Autonomy makes headlines. Augmentation makes better care.

There’s this idea that AI in eye care only becomes real when it works on its own.

Diagnosing, deciding, acting independently.

But that’s not what most of us actually need in clinic.

The AI tools that are being used in optometry and ophthalmology don’t replace your judgment. They help with triage. They highlight patterns. They flag what deserves a closer look.

They assist.

When AI reduces cognitive load, something important happens: you get time back.

Time to sit with the patient. Time to ask the right questions. Time to explain what those subtle changes in the retina mean. Time to show the images, visualisations and talk through risk, next steps and outlook in a calm, factual way. Time to make the patient understand and feel calm about the process.

Better conversations. Less rush. More clarity.

That’s why we prefer the term augmented intelligence. Not because it sounds nicer, but because it reflects reality. The goal isn’t autonomy. The goal is better care.

Better care often starts with better communication.

16/02/2026

Calling everyone who has tried the new 3D visualization in RetinaLyze Glaucoma AI

We’ve had great feedback from optometrists and ophthalmologists who explored the new 3D visualization feature.

Now we would love to hear from you 👇

What is the most interesting aspect of the 3D visualization?
- Better clinical confidence
- Improved patient dialogue
- Better use of existing devices
- Unlock new value from 2D image

Share your opinion in the comments below!

11/02/2026

Thank you MIDO and opti 2026 🙌

What a fantastic start to the year.

Over the past weeks in Milan 🇮🇹 and Munich 🇩🇪, we had the pleasure of meeting so many friends, partners, customers, and curious minds from across the eye care ecosystem. Inspiring conversations, sharp questions, and a shared ambition to move eye care forward.

At RetinaLyze System A/S, we’re grateful to everyone who stopped by to discuss AI-supported retinal screening, real-world workflows, and how technology can support clinical judgment rather than replace it.
A big thank you to our partners and hosts, including Topcon Healthcare, Topcon Healthcare Europe, Topcon Deutschland Medical, FE-Group srl, Frastema Ophthalmics, Easyopht Group, RetinaLyze DACH, Likomed, TOMEY GmbH, and to the many industry colleagues from OCULUS Optikgeräte GmbH – International, Mediconsult AG, Rupp + Hubrach Optik GmbH, Breitfeld & Schliekert GmbH, and OPTIC-HANDEL FRAGSTEIN.

And of course, thank you to the people behind the conversations! You might have met Barbara Anthonsen, Michael Anthonsen, Kevin Körbs, and Patrick Körbs along the way.

We’re leaving both fairs energized, motivated, and reminded once again that trust, empathy, and professional expertise remain at the heart of healthcare.

See you at the next one.

09/02/2026

Two companies. One shared goal: better eye care through smarter collaboration.

In this video, Marius from Medibrix and Teddy from RetinaLyze introduce our new collaboration bringing together clinical expertise, data, and technology to support eye care professionals in everyday practice.

Clearer insights. Better decisions. Improved outcomes!

🎥 Watch the video to hear it directly from the two CEOs.

04/02/2026

What if you could see how much optic nerve tissue is still functioning?

With RetinaLyze Advanced Glaucoma, you can now assess rim volume.

Rim volume reflects the amount of axons passing through the opening of Bruch’s membrane.

In other words, how much functioning tissue remains in the optic nerve.

For glaucoma specialists, that’s a metric that speaks a familiar language.

This adds a new layer to glaucoma assessment:
• structural insight
• clinically meaningful
• easy to communicate to colleagues and patients

Developed in close dialogue with researchers and clinicians!

02/02/2026

“I’ll never beat the AI.”

A potential customer said this while talking about detecting the smallest changes on the retina.

And she’s right.
AI excels at precision and consistency.
But humans still win on emotional intelligence.

Asking the right questions.
Explaining findings with clarity and empathy.
Building trust when it matters most.

It’s not AI versus humans.
It’s AI supporting eye care professionals.
Expertise, not algorithms, stays in the driver’s seat.

Technology finds the signals.
People make the difference.

28/01/2026

is around the corner – see you in Milan 🇮🇹

From January 31 – February 2, 2026, the global optometry and ophthalmology community gathers at MIDO – and RetinaLyze will be there!

👉 You can experience RetinaLyze at two locations in Pavilion 3:
FE-Group srl / Frastema Ophthalmics / Easyopht Group: Booths C14, C20 & D13
Topcon Healthcare / Topcon Healthcare Europe: Booths M22 & N21

If you are curious about how AI-supported retinal screening can fit naturally into daily clinical or optical workflows, this is a great opportunity to see it in practice, ask questions, and exchange perspectives.

MIDO is all about innovation, collaboration, and real-world solutions – and we are looking forward to many good conversations with optometrists, ophthalmologists, and industry partners.

See you in Milan!

26/01/2026

Celebrating a powerful collaboration: RetinaLyze x Medibrix

At RetinaLyze, we believe that eye care workflows should be as seamless as the care professionals provide every day. That’s why we’re excited to highlight our cooperation with Medibrix!

A modular, web-based platform built to shape new clinical workflows through customizable, interoperable “bricks.”

Together, we’re helping clinics, optical chains, and healthcare organizations create smarter, more connected patient journeys.

Medibrix offers a full suite of bricks tailored for optometry and ophthalmology teams, including:
• Enterprise booking and smooth scheduling flows
• Pre- and post-visit questionnaires that reduce chair time
• Customer plans & targeted outreach to strengthen follow-up and retention
• Assisted and remote refraction for flexible service delivery
• Clinical decision support (CDSS) with integrated AI including RetinaLyze’s instant retinal analysis
• Optical Resource Centers that unify data, devices, and processes

By integrating RetinaLyze® AI screening into the Medibrix ecosystem, we’re helping eye care professionals deliver faster, more standardized and preventive care. Whether they’re in a single practice, a large chain, or part of a broader healthcare network.

A big thank you to the teams at Medibrix, and our partners across optometry and ophthalmology who continue to push innovation forward.

Here’s to building the future of eye care, one brick at a time. 👁️✨

21/01/2026

The redesigned clinical PDF report is now available to all customers.

This revamped report is built to improve clarity and communication at every step of the eye care workflow.

With a cleaner, more modern layout and integrated visual elements, including high-quality retinal images, OCT scans, and AI overlays, clinicians can now share findings with colleagues and patients more intuitively than ever before.

Whether you’re making a referral, explaining results to a patient, or collaborating across care teams, this report brings key insights forward at a glance.

Clear definitions of triage outcomes and a patient-friendly glossary enhance understanding and support informed decision-making. We’ve aligned the format across modalities, from diabetic retinopathy to glaucoma as well as fundus to OCT, bringing consistency and confidence to clinical documentation.

A step forward in how we communicate eye health! Thanks to all our partners and users who continue to shape better care together.

Adresse

Mileparken 10C
Skovlunde
2740

Åbningstider

Mandag	09:00 - 17:30
Tirsdag	09:00 - 17:30
Onsdag	09:00 - 17:30
Torsdag	09:00 - 17:30
Fredag	09:00 - 17:30

Internet side

https://retinalyze.com/

Underretninger

Vær den første til at vide, og lad os sende dig en email, når RetinaLyze International sender nyheder og tilbud. Din e-mail-adresse vil ikke blive brugt til andre formål, og du kan til enhver tid afmelde dig.

Kontakt Praksis

Send en besked til RetinaLyze International:

Genveje

Vil du plassere din praksis på toppen av Klinik-listen i Skovlunde?

Del

Prevention of blindness through AI

RetinaLyze prevents loss of eyesight by making eye screening accessible. 80% of all blindness is preventable. Early screening and diagnosis is crucial and possible with Retinalyze' automated retinal screening tools and telemedicine solutions. Our mission is to make it easier for people all over the world to have their eyes tested and prevent the tragic consequences caused by late treatment of retinal lesions.

RetinaLyze® is a screening software, which helps eye care professionals perform screenings for eye diseases in a safe and efficient manner. The automated algorithm (AI) module detects eye diseases by analyzing fundus images. It can be used as a clinical decision support system (CDSS) or as a screening tool in conjunction with the telemedicine module. Retinalyze System A/S is a registered company in Denmark. Check us out at https://RetinaLyze.com.